BST Stock Overview
Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Biotechnology Assets, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.33 |
| 52 Week High | €0.50 |
| 52 Week Low | €0.31 |
| Beta | 1.27 |
| 1 Month Change | -10.09% |
| 3 Month Change | -13.25% |
| 1 Year Change | -25.78% |
| 3 Year Change | -54.86% |
| 5 Year Change | -85.29% |
| Change since IPO | -85.85% |
Recent News & Updates
Shareholder Returns
| BST | ES Biotechs | ES Market | |
|---|---|---|---|
| 7D | -0.6% | 6.3% | 2.7% |
| 1Y | -25.8% | -14.9% | 17.9% |
Return vs Industry: BST underperformed the Spanish Biotechs industry which returned -11% over the past year.
Return vs Market: BST underperformed the Spanish Market which returned 17% over the past year.
Price Volatility
| BST volatility | |
|---|---|
| BST Average Weekly Movement | 4.6% |
| Biotechs Industry Average Movement | 7.4% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in ES Market | 6.9% |
| 10% least volatile stocks in ES Market | 1.1% |
Stable Share Price: BST has not had significant price volatility in the past 3 months.
Volatility Over Time: BST's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 37 | Jaime Feced Rubio | www.biatgroup.com |
Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.
Biotechnology Assets, S.A. Fundamentals Summary
| BST fundamental statistics | |
|---|---|
| Market cap | €19.28m |
| Earnings (TTM) | €1.57m |
| Revenue (TTM) | €3.91m |
12.3x
P/E Ratio4.9x
P/S RatioIs BST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BST income statement (TTM) | |
|---|---|
| Revenue | €3.91m |
| Cost of Revenue | €450.59k |
| Gross Profit | €3.46m |
| Other Expenses | €1.88m |
| Earnings | €1.57m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.027 |
| Gross Margin | 88.47% |
| Net Profit Margin | 40.27% |
| Debt/Equity Ratio | 62.7% |
How did BST perform over the long term?
See historical performance and comparison